#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12764	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2113	601.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1701	1701	T	713	T	655	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12764	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2113	601.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1435	1435	C	796	C	743	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3635	650.2	0	.	n	.	0	T695C	SNP	695	695	T	1014	1014	C	697	C,A,T	644,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3635	650.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1656	1656	A	787	A,G	736,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3635	650.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2290	2290	C	760	C,T	695,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3635	650.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2364	2364	A	756	A	707	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3635	650.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2916	2916	C	759	C	699	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23700	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3635	650.2	0	HET	.	.	.	C993T	.	993	993	C	1312	1312	C	757	C,T	423,269	.	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	62362	blaTEM	861	861	99.88	blaTEM.l15.c17.ctg.1	1611	3858.5	0	.	p	.	0	M180T	NONSYN	538	540	ATG	910	912	ACG	6268;6255;6236	A,T;C,T;G,A,C	5721,1;5770,1;5723,1,1	.	Betalactam resistance
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1614	folP	855	855	100.0	folP.l15.c4.ctg.1	1635	98.3	1	SNP	p	R229S	1	.	.	685	687	AGC	1100	1102	AGC	136;137;136	A;G;C	127;130;126	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4618	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3411	135.0	1	SNP	p	S91F	1	.	.	271	273	TTC	563	565	TTC	135;137;138	T;T;C	131;132;133	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4618	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3411	135.0	1	SNP	p	D95G	1	.	.	283	285	GGC	575	577	GGC	139;140;139	G;G;C	132;133;129	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4618	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3411	135.0	1	SNP	p	G95N	0	.	.	283	285	GGC	575	577	GGC	139;140;139	G;G;C	132;133;129	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_W_01449	mtrR.WHO_W_01449	1	1	539	1416	mtrR	633	633	99.37	mtrR.l15.c4.ctg.1	1279	109.7	0	.	p	.	0	A39T	NONSYN	115	117	GCC	498	500	ACC	162;160;160	A;C;C	151;153;150	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	768	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	998	76.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4062	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2897	139.6	1	SNP	p	D86N	1	D86N	NONSYN	256	258	GAC	609	611	AAC	157;159;160	A;A;C	145;145;148	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4062	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2897	139.6	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1656	1658	GCA	186;186;185	G;C;A	172;168;166	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4062	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2897	139.6	1	SNP	p	S87R	0	.	.	259	261	AGT	612	614	AGT	159;159;159	A,G;G;T	146,1;147;147	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4062	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2897	139.6	1	SNP	p	S87I	0	.	.	259	261	AGT	612	614	AGT	159;159;159	A,G;G;T	146,1;147;147	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4062	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2897	139.6	1	SNP	p	S87W	0	.	.	259	261	AGT	612	614	AGT	159;159;159	A,G;G;T	146,1;147;147	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4062	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2897	139.6	1	SNP	p	S88P	0	.	.	262	264	TCC	615	617	TCC	159;160;159	T;C;C	146;148;146	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3744	parE	1986	1986	99.85	parE.l15.c4.ctg.1	2623	142.3	0	.	p	.	0	V89A	NONSYN	265	267	GTC	530	532	GCC	178;181;181	G;C;C	160;167;161	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3744	parE	1986	1986	99.85	parE.l15.c4.ctg.1	2623	142.3	0	.	p	.	0	P496S	NONSYN	1486	1488	CCC	1751	1753	TCC	176;175;171	T,C;C;C	164,1;165;161	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3744	parE	1986	1986	99.85	parE.l15.c4.ctg.1	2623	142.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1493	1495	GGC	197;193;192	G;G;C	180;177;175	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	3496	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2306	150.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1210	1212	GCA	207;207;209	G;C;A	191;190;197	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3496	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2306	150.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1213	1215	ATC	210;209;209	A;T;C	196;193;193	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3496	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2306	150.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1225	1227	GTG	204;204;206	G;T;G	190;191;191	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3496	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2306	150.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1225	1227	GTG	204;204;206	G;T;G	190;191;191	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3496	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2306	150.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1729	1731	ACC	194;195;195	A;C;C	178;181;179	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3496	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2306	150.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1783	1785	GCG	190;191;187	G;C;G	162;142;157	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3496	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2306	150.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1783	1785	GCG	190;191;187	G;C;G	162;142;157	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3496	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2306	150.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1906	1908	GGC	154;154;156	G;G;C	148;144;149	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3496	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2306	150.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1915	1917	GGC	154;152;152	G;G;C	144;140;140	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	3496	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2306	150.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1933	1935	CCG	136;138;137	C,G;C,G;GCCC,GCCCC,GGCCCC	89,5;91,2;86,1,1	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5116	ponA	2397	2397	99.87	ponA.l15.c30.ctg.1	3122	163.5	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1489	1491	ACG	216;214;213	A;C;G	195;197;192	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5116	ponA	2397	2397	99.87	ponA.l15.c30.ctg.1	3122	163.5	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1627	1629	CTG	200;203;205	C;T;G	177;183;183	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1924	porA	1146	1146	99.65	porA.l6.c4.ctg.1	1784	107.4	0	.	p	.	0	S22G	NONSYN	64	66	AGC	332	334	GGC	129;129;129	G;G;C	122;124;123	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1924	porA	1146	1146	99.65	porA.l6.c4.ctg.1	1784	107.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	514	514	C	131	C	122	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2390	porB1a	984	984	99.7	porB1a.l15.c17.ctg.1	1316	178.8	0	.	p	.	0	Y39H	NONSYN	115	117	TAC	305	307	CAC	211;213;212	C;A;C	190;195;198	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2390	porB1a	984	984	99.7	porB1a.l15.c17.ctg.1	1316	178.8	0	.	p	.	0	H111R	NONSYN	331	333	CAT	521	523	CGT	200;199;200	C;G;T	182;182;184	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	539	2390	porB1a	984	984	99.7	porB1a.l15.c17.ctg.1	1316	178.8	0	.	p	.	0	D120G	NONSYN	358	360	GAC	548	550	GGC	200;201;198	G;G;C,A	187;186;183,1	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9878	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4772	206.2	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1986	1988	AAT	203;203;202	A;A;T	192;191;189	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1104	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1085	101.0	1	SNP	p	V57M	1	.	.	169	171	ATG	531	533	ATG	247;245;239	A;T;G	229;228;226	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	12436	tetM	1920	1920	100.0	tetM.l6.c17.ctg.1	2455	503.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
